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The inclusion complexes of poorly water-soluble cephalosporin, cefuroxime axetil (CFA), were prepared
with β-cyclodextrin (βCD) with or without addition of L-arginine (ARG) to improve its physicochemical
properties. We also investigated the effect of ARG on complexation efﬁciency (CE) of βCD towards CFA in
an aqueous medium through phase solubility behaviour according to Higuchi and Connors. Although
phase solubility studies showed AL (linear) type of solubility curve in presence and absence of ARG, the
CE and association constant (Ks) of βCD towards CFA were signiﬁcantly promoted in presence of ARG,
justifying its use as a ternary component. The solid systems of CFA with βCD were obtained by spray
drying technique with or without incorporation of ARG and characterized by differential scanning ca-
lorimetry (DSC), X-ray powder diffractometry (XRPD), scanning electron microscopy (SEM), and sa-
turation solubility and dissolution studies. The molecular modeling studies provided a better insight into
geometry and inclusion mode of CFA inside βCD cavity. The solubility and dissolution rate of CFA were
signiﬁcantly improved upon complexation with βCD as compared to CFA alone. However, ternary system
incorporated with ARG performed better than binary system in physicochemical evaluation. In conclu-
sion, ARG could be exploited as a ternary component to improve the physicochemical properties of CFA
via βCD complexation.
& 2016 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cefuroxime axetil (CFA) (Fig. 1) is a β-lactamase-stable 1-acet-
oxyethyl ester prodrug of cefuroxime cephalosporin with high
effectiveness against gram-positive and gram-negative micro-
organisms. It is used orally to treat respiratory tract infections,
pharyngitis, tonsillitis, acute bacterial otitis, urinary tract infec-
tions and uncomplicated skin infections. The important structural
feature of CFA is the presence of lipophilic 1-acetoxyethyl ester
which facilitates its intestinal absorption after oral administration.
However, CFA exists in crystalline and amorphous state and has
poor aqueous solubility and dissolution rate in gastrointestinal
tract. Consequently, these physicochemical properties of CFA are
responsible for its limited and variable oral bioavailability (30%–
60%) [1–5], resulting in poor therapeutic outcome.
Cyclodextrins (CDs) are cyclic oligosaccharides with hydro-
phobic central cavity and hydrophilic exterior, rendering them ason and hosting by Elsevier B.V. Th
University.
ore).powerful complexing and solubilizing agents [6–8]. They are
classiﬁed into α-, β- and γ-CDs consisting of (α1, 4)-linked six,
seven and eight α-D-glucopyranose units, respectively [9]. The
inclusion complexation of drug (guest) molecules with CDs (host)
is an industrially feasible technique used to improve the physi-
cochemical properties of the drug, such as solubility, dissolution
rate, and bioavailability [10–12]. Unfortunately, due to lower
complexation efﬁciency (CE) of CDs, solubility enhancement via
cyclodextrin (CD) complexation is limited to certain extent [13].
Several papers have reported enhancement in CE of CDs with the
addition of small amounts of hydrophilic polymers [14,15], hy-
droxyl acids [16,17] and/or amino acids [9,18–21] as ternary
components to the complexation media resulting in the formation
of ternary complexes. The basic amino acid, L-arginine (ARG), was
proved to be a better choice as an auxiliary substance to increase
the solubilizing capacity of CDs through electrostatic interaction
and salt formation during the multi-component complex forma-
tion of weekly acidic drugs [21,22]. Thus, considering the ad-
vantage of incorporation of amino acid as a ternary component
during complexation of drug with CD, the proposed work was
carried out to promote the physicochemical properties of poorlyis is an open access article under the CC BY-NC-ND license
Fig. 1. Chemical structure of cefuroxime axetil.
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ARG as an auxiliary substance, which to our knowledge has not
been reported yet.
The present study primarily focused on the investigation of the
physicochemical properties of the inclusion complexes of CFA with
βCD in presence of ARG as a ternary component. Initially, the
possibility of complex formation was studied by molecular
modeling approach and subsequently by phase solubility mea-
surements to determine the stoichiometry of the complex for-
mation. The binary and ternary inclusion complexes were pre-
pared by spray drying method and characterized by differential
scanning calorimetry (DSC), X-ray powder diffractometry (XRPD)
and scanning electron microscopy (SEM). The saturation solubility
and dissolution experiments were further conducted in distilled
water and 0.07M HCl respectively to examine the physicochemical
performance of the prepared complexes.2. Experimental
2.1. Materials and reagents
CFA was obtained as a gift sample from Okasa Pharma Ltd.
(Satara, India). βCD (Average molecular weight 1135 g/mol, purity
98%) was purchased from Himedia Laboratories Pvt., Ltd. (Mumbai,
India). ARG (purity 99%) was procured from Loba Chemie Pvt., Ltd.
(Mumbai, India). Analytical grade chemicals and double distilled
water were used for all experimental procedures. All substances
were used directly without further puriﬁcation.2.2. Molecular modeling studies
Molecular modeling simulations were performed using VLifeMDS
4.3 software Suit (VLife Sciences and Technologies, Pune, India) on
Intel i3 CORE processor operated with Windows XP. The molecular
structure of βCDwas downloaded from Pubchem Structural Database
(CID444041). The chemical structure of CFA was built on workspace
of VLife Engine module. The individual structures (2D) of host and
guest were converted to 3D and optimized to achieve minimum
energy using Merck Molecular Force Field (MMFF) program with
RMS gradient of 0.01 kcal/mol and dielectric constant of 1. Subse-
quently, CFA was allowed for conformational analysis using Monte
Carlo simulations. One of the CFA conformers with least energy was
positioned into the βCD cavity at different orientations and the
structures were again minimized. The stoichiometry of the complex
formation showing least energy was considered optimum from the
total energies obtained after optimization of 1:1, 1:2 and 2:1 stoi-
chiometries of CFA:βCD complexes. The stability of the complex was
predicted from relative thermodynamic relationship in molecular
mechanic (MM) calculations by calculating complexation energies
(ΔE) [23,24].2.3. Phase solubility studies
The solubility behaviour of CFA was examined in distilled water
at room temperature (2572 °C) according to the method de-
scribed by Higuchi and Connors [25]. Excess amount of CFA was
added to 20 mL of aqueous solutions containing various con-
centrations of βCD (0–0.01 M) with or without addition of ARG
(0.25%, m/v). The suspensions were mechanically shaken subse-
quently on a rotary shaker for 72 h at 125 rpm until equilibrium
was achieved. The samples were ﬁltered through Whatman ﬁlter
paper 41, diluted if necessary and analyzed spectrophotometrically
(Shimadzu UV–vis spectrophotometer 1800, Japan) at 281 nm. The
association constant (Ks) of complex and CE of βCD were calcu-
lated according to the Eqs. (1) and (2), respectively [26].
= ( − ) ( )K Slope S Slopes / 1 10
S0 is the solubility of CFA in absence of βCD and slope is obtained
from the phase solubility diagram constructed by plotting concentra-
tion of drug on y-axis and concentration of βCD on x-axis. It gives idea
about the stoichiometry of the complex formation. Linear dependence
of drug concentration to βCD concentration, with slope ratio below
one, usually assumes 1:1 ratio of the complex and refers to AL (linear)
type of the phase solubility curve.
= ⋅ = ( − ) ( )CE S K Slope Slope/ 1 20 1:1
The thermodynamic parameter, Gibbs free energy of transfer (Δ
Gtr°), was also determined with the following equation:
( )Δ ° = − ( )G S S2.303RTlog / 3tr c 0
Where Sc/S0 is the ratio of molar solubility of CFA in aqueous
solutions of βCD with or without ARG to that in distilled water in
absence of βCD. ΔGtr° values demonstrate the process of transfer
of CFA from pure water to aqueous solutions of βCD [5].
2.4. Preparation of binary and ternary inclusion complexes
Equimolar quantities of CFA and βCD with or without addition
of ARG (0.25%, m/v) were dissolved in 100 mL of methanol and
sonicated for 10 min. The mixture was stirred for 72 h at room
temperature (2572 °C) on a magnetic stirrer (2MLH, Remi La-
boratory Instruments, Mumbai, India) at 125 rpm. The resultant
suspension was spray dried using Lab spray dryer (SPD-D-111
Techno Search Instruments, Thane, India) under the following set
of conditions: Inlet temperature 65 °C, outlet temperature 45 °C,
cool temperature 20 °C, aspirator speed 40 mBar and feed rate
5 mL/min. The spray dried product was collected and stored in
desiccators to prevent it from moisture absorption.
2.5. DSC analysis
Thermograms of CFA, βCD, ARG and complexes were recorded
on a DSC analyzer (Mettler DSC 823E Mettler Toledo Pvt. Ltd,
Switzerland). A sample (5 mg) was placed in an aluminum pan and
heated under a nitrogen atmosphere (ﬂow rate 100 mL/min) at a
heating rate of 10 °C/min over the temperature range of 30–300 °C.
The thermal behaviour of samples was recorded and studied.
2.6. XRPD analysis
The XRPD analysis of all samples including pure CFA was per-
formed using X-ray diffractometer (PW 1729, Philips, the Netherland)
with copper (Cu) anode, generator tension 40 kV, generator current
30 mA, and scanning speed 2°/min over the interval of 10–90°/2θ.
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The surface morphological features of all samples were in-
vestigated using a scanning electron microscope (SEM-JOEL In-
struments, JSM-6360, Japan) operated at an acceleration voltage of
20 kV and the obtained microphotographs were examined at
500 and 2000 magniﬁcations.
2.8. Saturation solubility studies
Saturation solubility studies of CFA and inclusion complexes
were conducted in triplicate as follows: an excess amount of CFA
and/or complexes were added to 20 mL of distilled water in vials
sealed with stoppers and shaken in a rotary ﬂask shaker at room
temperature (2570.5 °C) for 24 h. A portion of solution was
withdrawn, ﬁltered through Whatman ﬁlter paper 41 and ana-
lyzed spectrophotometrically (Shimadzu UV–vis spectro-
photometer 1800, Japan) at 280 nm. The data of saturation solu-
bility were analyzed statistically using ANOVA (Instats, GraphPad
software Inc. Version 3.05).
2.9. Dissolution studies
The dissolution studies of CFA and complexes were carried out in
eight station dissolution test apparatus (Disso 2000 Tablet dissolution
test apparatus, Lab India, Mumbai, India) according to USP type II. A
total of 125 mg of pure CFA or complexes were added into a dissolu-
tion vessel containing 900 mL of 0.07 M HCl, maintained at 3770.5 °C
at 55 rpm. A total of 6 mL of samples were withdrawn at appropriate
time intervals. The volume of dissolution medium was adjusted to
900 mL by replacing each 6 mL of aliquot withdrawn with 6 mL of
fresh 0.07 M HCl. The solution was immediately ﬁltered through
Whatman ﬁlter paper 41, suitably diluted and analyzed spectro-
photometrically (Shimadzu UV–vis spectrophotometer 1800, Japan) at
281 nm. The data of dissolution studies were analyzed statistically
using ANOVA (Instats, GraphPad software Inc. Version 3.05).3. Results and discussion
3.1. Molecular modeling studies
The possibility of complex formation was assessed with the
molecular mechanic calculations. The total energies of complex
formation for 1:1, 1:2, 2:1 stoichiometries were found to be 422.5,
9072, and 4235 kcal/mol, respectively. As the lowest total energy
was shown by 1:1 stoichiometry of CFA:βCD inclusion complex, it
was considered to be the most stable inclusion complex among all
the stoichiometries examined (Fig. 2).
As shown in Fig. 2, insertion of furan ring from narrow rim of
βCD (Fig. 2A) and insertion of dihydrothiazine ring fromwider rim
of βCD (Fig. 2B) were the most appropriately predicted inclusion
geometries for binary and ternary complexes, respectively, corre-
sponding to the greatest absolute value of heat of formation and
the lowest complexation energies (ΔE) (Table 1) [23].
Thus, it could be concluded that βCD could accommodate furan
ring from narrow rim inside the βCD cavity in absence of ARG
while insertion of dihydrothaizine moiety in βCD cavity was fa-
vored through wider rim in presence of ARG, indicating ARG in-
volvement in the hydrogen bonding interactions with βCD and
CFA outside the βCD cavity.
3.2. Phase solubility studies
The phase solubility diagrams of CFA in aqueous βCD solution
in presence and absence of 0.25% ARG exhibited AL type ofsolubility curve with linear increase in solubility of CFA upon in-
creasing the concentration of βCD (Fig. 3).
The slopes of phase solubility curves were less than 1, indicat-
ing the formation of water soluble complexes with 1:1 stoichio-
metry [13,25]. As shown in Table 2, the values of S0, slopes, Ks, and
CE of complex increased with the addition of ARG to the com-
plexation media, indicating greater effectiveness of ternary sys-
tems over binary one.
This enhancement in phase solubility parameters of CFA upon
complexation with βCD in presence of ARG might be attributed to
its electrostatic/hydrogen bonding interaction and salt formation
with βCD and CFA [11,19]. In addition to that, molecular interac-
tions based on solublization of the drug such as hydrophobic
bonding, Van der Waals dispersion forces and/or promoting the
release of high-energy water molecules present in the cavity
might have also contributed to beneﬁcial effects of ARG as a
ternary component [20–22,26].
Table 3 shows Gibbs free energy change (ΔGtr°) values to
predict the thermodynamics of process of transfer of CFA from
pure water to aqueous solution of βCD.ΔGtr° values were found to
be negative at various concentrations of βCD in all cases, indicating
the spontaneous nature of CFA solubilization. The values were
decreased upon increasing concentration of βCD, indicative of
more favorable solubilization reaction as the concentration of βCD
increased [5,11,27].
These values indicated that the system was releasing energy
upon complexation undergoing Vander Waals and electrostatic
interactions and became more favorable in presence of ARG, sug-
gesting its effectiveness as ternary component to prepare ternary
systems.
3.3. DSC analysis
DSC technique has attracted attention to examining the inter-
action between host and guest molecules during the complex
formation. When guest molecules are embedded in the βCD cavity,
their melting points usually shift to a different temperature or
disappear [22,28]. The thermograms of CFA, βCD, ARG and their
complexes are shown in Fig. 4.
The DSC curve of CFA (Fig. 4a) exhibited glass transition tem-
perature (Tg) at 86.52 °C, indicating its amorphous nature. The
appearance of a broad endotherm at 134.02 °C in DSC curve of βCD
was attributed to loss of water from βCD cavity (Fig. 4b). ARG
exhibited broad peaks (Fig. 4c) at 93.45 and 99.55 °C due to loss of
water of crystallization from small portions of L-arginine 2H2O and
two melting endotherms at 225.83 and 232.96 °C with different
intensities, indicating melting with decomposition of anhydrous
ARG and total decomposition of the melt, respectively [20,22].
The binary and ternary complexes showed appearance of broad
peaks at 110.76 °C and 120.84 °C, respectively (Fig. 4d and e), as-
signable to water loss and disappearance of Tg of CFA ensuring
entrapment of CFA inside βCD cavity with replacement of water
molecules. The peaks of ARG also disappeared in ternary systems,
indicating ARG involvement in the complexation process. These
results strongly suggested an existence of strongly physical inter-
action between CFA and βCD and formation of stable inclusion
complex in solid state.
3.4. XRPD analysis
The physical state of pure drug and its complexes could be
assessed by examining their XRPD patterns as shown in Fig. 5. The
diffractogram of CFA (Fig. 5a) exhibited diffused peaks, indicating
its amorphousness. However, there were certain peaks still de-
tectable at 2θ° values of 11.17 (515), 13.95 (642), 16.42 (715), 19.28
(979), 20.23 (949), 21.49 (1026), 22.18 (982), 22.93 (977), 23.56
Fig. 2. Optimized geometric models of (A) CFA:βCD binary system (B) CFA:ARG:βCD ternary system.
Table 1
Enthalpies (ΔH) and complexation energies (ΔE) of optimized CFA:βCD binary and
CFA:ARG:βCD ternary complexes (kcal/mol).
Possible geometries of
CFA inside βCD cavity
CFA:βCD CFA:ARG:βCD
ΔH ΔE ΔH ΔE
Furan ring in narrow
rim
63,552 157.5 708,902 305.63
Furan ring in wider rim 13,207 30.5 746,427 663.34
Dihydrothiazine ring
in narrow rim
98,571 30.5 352,425 21.5
Dihydrothiazine ring
in wider rim
2,099,959 655.41 132073.03 27.5
Enthalpy (ΔH): Enthalpy of formation of complex – sum of enthalpies of formation
of guest and host; Complexation energy (ΔE): Energy of the complex – sum of the
energies of guest and host in their respective equilibrium geometry; CFA: cefur-
oxime axetil; βCD: β-cyclodextrin; ARG: L-arginine.
Fig. 3. Phase solubility diagram of CFA:βCD inclusion complexes in water at
2572 °C. CFABC: binary system; CFATC: ternary system with ARG.
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crystalline traces in the diffractogram of CFA. The crystalline
nature of βCD was clearly shown by the appearance of sharp peaks
at 10.60 (807), 10.71 (539), 11.94 (639), 12.57 (786), 12.49 (1111),
12.37 (1404), 12.41 (1349), 15.29 (700), 17.07 (982), 19.50 (1128),
20.74 (1070), and 22.56 (902) in its diffractogram (Fig. 5b). ARG
displayed major peaks at 11.19 (519), 14.88 (1004), 16.63 (850),
19.26 (2111), 23.09 (3126), and 27.55 (3560) in crystalline state
(Fig. 5c).The examination of XRPD patterns of binary (Fig. 5d) and
ternary (Fig. 5e) complexes showed maximum appearance of
peaks of βCD and an absence of crystalline traces of CFA, con-
ﬁrming spatial entrapment of CFA inside βCD cavity. In ternary
systems, the overlapping of βCD and ARG crystalline peaks was
noticed. However, the peaks of ARG were diffused to certain extent
due to solid state interaction during complex formation [9].
Table 2
Phase solubility data of binary and ternary inclusion complexes of CFA with βCD.
Complexes S0 Slope r2 Ks (M1)a KTS/KBS CE
CFA:βCD 0.00051 0.1485 0.9922 339.7471.5 – 0.17
CFA:ARG:βCD 0.00054 0.2096 0.9989 490.9872.7b 1.44 0.27
CFA: cefuroxime axetil; βCD: β-cyclodextrin; ARG: L-arginine; S0: solubility of CFA in
absence of βCD; r2: regression coefﬁcient of phase solubility plot; Ks (M1): asso-
ciation constant of complexes; KTS/KBS: the ratio of Ks for ternary and binary sys-
tems; CE: complexation efﬁciency.
a indicates mean7SD (n¼3); SD: Standard deviation.
b Signiﬁcant difference compared to Ks of βCD binary system (po0.001).
Table 3
Gibbs free energy of transfer (ΔGtr°) of CFA from pure water to aqueous solutions of
βCD in presence and absence of auxiliary substance ARG (0.25%, m/v).
Concentration of βCD (mmol/L) ΔGtr° (J/mol)
CFA:βCD CFA:ARG:βCD
0.002 108.82 139.67
0.004 146.97 212.80
0.006 221.53 265.05
0.008 254.39 309.59
0.010 284.66 342.30
CFA: cefuroxime axetil; βCD: β-cyclodextrin; ARG: L-arginine.
Fig. 4. DSC thermograms of CFA (a), βCD (b), ARG (c), CFA:βCD binary system (d)
and CFA:ARG:βCD ternary system (e).
Fig. 5. XRPD patterns of CFA (a), βCD (b), ARG (c), CFA:βCD binary system (d), and
CFA:ARG:βCD ternary system (e).
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The surface morphological features of pure CFA and complexes
are shown in Fig. 6. Pure CFA appeared as amorphous broken
spherical particles as separate entities (Fig. 6A). There were distinct
changes observed in morphology of spray dried complexes. The
particles of binary complexes exhibited altered shape and showed
bulky spherical agglomerate type morphology (Fig. 6B) due to crys-
talline nature of βCD. The crystalline nature of βCD and ARG also
further contributed to change in morphology of ternary complexes
(Fig. 6C) showing characteristic bulky agglomerated crystalline
structure images. The alteration in the morphology of particles in
spray dried complexes conﬁrmed the presence of a new solid phase
in the complex achieving maximum complexation [29].
3.6. Saturation solubility studies
The saturation solubility studies of binary and ternary systems
showed remarkable enhancement in the solubility as compared to
pure CFA (po0.001). Pure CFA exhibited a solubility of
Fig. 6. SEM of (A) CFA, (B) CFA:βCD binary system and (C) CFA:ARG:βCD ternary system.
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plexes showed solubility of 8.6670.30 and 16.8770.72 mg/mL, re-
spectively. There was 24.39 fold increment in the solubility of binary
complex observed, whereas 47.50 fold increment in the solubility of
ternary complex was noted, which was almost double than that of
binary complex. The enhancement in solubility of complex was at-
tributed to the formation of stable inclusion complex of CFA with
βCD. In ternary systems, ARG played a signiﬁcant role as a ternary
component resulting in better performance than binary system.
The improvement in water solubility of CFA from the com-
plexes could be explained in terms of wetting property and hy-
drophilicity of βCD, altered surface morphological features of the
complexes due to spray drying technique and inclusion into the
hydrophobic βCD cavity [30].
3.7. Dissolution studies
The dissolution curves of CFA and spray dried complexes areshown in Fig. 7. According to the results, an increment in dis-
solution proﬁle was noted for solid complexes as compared to
pure CFA (po0.001). The binary systems showed almost complete
drug release in 60 min. Indeed, ternary complexes demonstrated
faster dissolution proﬁle than binary complexes with 99.87% drug
release within 25 min in dissolution media. However, the release
of pure drug was incomplete even in 90 min.
The signiﬁcant improvement in dissolution rate of CFA from
inclusion complexes could be ascribed to greater hydrophilicity,
wetting property, increased contact between the drug and βCD
due to spray drying technology and ability to form stable inclusion
complex with βCD [30]. The greater effectiveness of ternary
complex for higher release rate was due to positive effect of ad-
dition of basic amino acid ARG which drastically promoted phase
solubility parameters such as Ks and CE, interacting simulta-
neously both with βCD (via hydrogen bonding) and CFA (via
electrostatic interactions and salt formation) [11,22,31]. Thus, it
Fig. 7. The dissolution proﬁle of CFA, binary and ternary inclusion complexes at
3770.5 °C. CFA: cefuroxime axetil; CFABC: binary system; CFATC: ternary system
with ARG.
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could be a reliable approach for improved dissolution properties.4. Conclusions
The present study demonstrated a successful application of basic
amino acid ARG as a ternary component to improve the physico-
chemical properties of CFA via ternary complexation with βCD. The
signiﬁcant enhancement in association constant and complexation
efﬁciency of βCD towards CFA in presence of ARG could be possibly
helpful in reducing the workable amount of βCD during formulation
of complexes. In conclusion, CFA can form stable inclusion complexes
with βCD in presence of ARG as an auxiliary substance to offer
ternary systems with better performances.Acknowledgments
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